UMIT International Oncology Center for Tomotherapy, LLP | Kazakhstan
Dr. Berikbol Daulet is a medical researcher at the UMIT International Oncological Center of Tomotherapy, Astana, Kazakhstan, with expertise in radiation oncology, tomotherapy, and advanced cancer treatment strategies. His research focuses on integrating precision radiotherapy with immunological and cellular therapies to improve outcomes in complex and advanced-stage cancers. He has authored 4 peer-reviewed publications, received 2 citations, and holds an h-index of 1, reflecting focused and emerging contributions to clinical oncology. Dr. Daulet actively engages in multidisciplinary clinical and translational research, contributing to collaborative studies that bridge radiotherapy and immunotherapy. His recent open-access case report on combined tomotherapy and autologous peripheral-blood–derived lymphocyte infusion for stage IIIa lung cancer highlights innovative, patient-centered treatment approaches, particularly for elderly patients. Through applied clinical research, he supports evidence-based oncology practice, advances modern cancer treatment technologies, and contributes to improved patient outcomes and broader societal benefit in healthcare.
Citation Metrics (Scopus)
View Scopus Profile View ORCID Profile
Featured Publications
